Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Market Closed - Bombay S.E. Other stock markets 03:30:46 06/03/2026 pm IST			5-day change	1st Jan Change
356.85 ^INR	-1.01%		-2.77%	-13.35%

04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Aarti Drugs dividend 2 rupees per share	RE

Transcript : Aarti Drugs Limited, Q3 2023 Earnings Call, Jan 30, 2023

Published on 01/30/2023 at 03:30 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to Aarti Drugs Limited Q3 FY '23 Earnings Conference Call. This conference call may contain forward-looking

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Aarti Drugs Limited

04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Aarti Drugs dividend 2 rupees per share	RE
03/02	Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
03/02	Aarti Drugs Dec-quarter Consol Net Profit 405.4 Million Rupees	RE
03/02	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2025-26	CI
10/11	Aarti Drugs Limited, Q2 2026 Earnings Call, Nov 10, 2025
08/11	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
05/25/05	Aarti Drugs Sayakha Plant Commences Commercial Production	MT
04/25/04	Aarti Drugs commences commercialization of manufacturing plant located at Sayakha	RE
21/25/21	Aarti Drugs Limited, Q1 2026 Earnings Call, Jul 21, 2025
18/25/18	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
07/25/07	Aarti Drugs Limited, Q4 2025 Earnings Call, May 07, 2025
07/25/07	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT
06/25/06	Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
06/25/06	Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees	RE